(Q39725373)

14 September 2017

IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer (English)

1 reference

14 September 2017

1 reference

Stefano Ugel

7

0 references

Sara Cingarlini

Sara Cingarlini

8

0 references

Giulio Innamorati

Giulio Innamorati

5

0 references

Silvia Sartoris

Silvia Sartoris

20

0 references

Paola Zanovello

Paola Zanovello

10

0 references

author name string

Matteo Martini

1

1 reference

14 September 2017

Maria Grazia Testi

2

1 reference

14 September 2017

Matteo Pasetto

3

1 reference

14 September 2017

Maria Cristina Picchio

4

1 reference

14 September 2017

Marta Mazzocco

6

1 reference

14 September 2017

Vincenzo Bronte

9

1 reference

14 September 2017

Mauro Krampera

11

1 reference

14 September 2017

Federico Mosna

12

1 reference

14 September 2017

Tiziana Cestari

13

1 reference

14 September 2017

Anna Pia Riviera

14

1 reference

14 September 2017

Nadia Brutti

15

1 reference

14 September 2017

Ottavia Barbieri

16

1 reference

14 September 2017

Lina Matera

17

1 reference

14 September 2017

Giuseppe Tridente

18

1 reference

14 September 2017

Marco Colombatti

19

1 reference

14 September 2017

language of work or name

English

0 references

publication date

19 March 2010

1 reference

14 September 2017

1 reference

14 September 2017

28

1 reference

14 September 2017

20

1 reference

14 September 2017

3548-3557

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

14 September 2017

1 reference

Genes to vaccines for immunotherapy: how the molecular biology revolution has influenced cancer immunology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

Correlation between major histocompatibility complex class I molecules and CD8+ T lymphocytes in prostate, and quantification of CD8 and interferon-gamma mRNA in prostate tissue specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

Loss of HLA class I expression in prostate cancer: implications for immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

Prostate cancer in a transgenic mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

Expression, specificity and immunotherapy potential of prostate-associated genes in murine cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

Costimulatory wars: the tumor menace

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

Induction of an antitumour adaptive immune response elicited by tumour cells expressing de novo B7-1 mainly depends on the anatomical site of their delivery: the dose applied regulates the expansion of the response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

TGF-beta: a master of all T cell trades

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

Immune Regulation by Mesenchymal Stem Cells Derived from Adult Spleen and Thymus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

Proteasome and peptidase function in MHC-class-I-mediated antigen presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

Molecular characterization of defective antigen processing in human prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

MHC class I and class II molecules are expressed in both human and mouse prostate tumor microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.007

10.1016/J.VACCINE.2010.03.007

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference